Atherosclerotic plaque composition and occurrence of Restenosis after carotid endarterectomy

被引:98
作者
Hellings, Willem E. [2 ]
Moll, Frans L. [2 ]
De Vries, Jean-Paul P. M. [3 ,4 ]
Ackerstaff, Rob G. A. [5 ]
Seldenrijk, Kees A. [6 ]
Met, Rosemarie [1 ]
Velema, Evelyn [1 ]
Derksen, Wouter J. M. [1 ]
De Kleijn, Dominique P. V. [1 ]
Pasterkamp, Gerard [1 ]
机构
[1] Univ Utrecht, Med Ctr, Expt Cardiol Lab, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Vasc Surg, NL-3584 CX Utrecht, Netherlands
[3] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands
[4] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands
[5] St Antonius Hosp, Dept Clin Neurophysiol, Nieuwegein, Netherlands
[6] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 299卷 / 05期
关键词
D O I
10.1001/jama.299.5.547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Previous studies have assessed the predictive value of clinical and angiographic parameters for development of restenosis after vascular interventions. The composition of the atherosclerotic plaque at the intervention site has not been evaluated as a marker for restenosis. Objective To investigate the relationship between atherosclerotic plaque histology and the occurrence of restenosis after carotid endarterectomy. Design, Setting, and Patients The Athero- Express study is a longitudinal vascular biobank study that includes the collection of atherosclerotic plaques of patients undergoing primary carotid endarterectomy. Five hundred patients were prospectively followed up between April 1, 2002, and March 14, 2006, to assess carotid artery restenosis measured by duplex ultrasound 1 year after the intervention. Main Outcome Measures Risk of carotid restenosis in relation to predefined histological characteristics ( macrophage and smooth muscle cell infiltration, collagen, calcifications, intraplaque bleeding, luminal thrombus, and lipid core size), adjusted for clinical characteristics ( multivariate logistic regression analysis). Results At 1 year, 85 patients ( 17%) developed 50% or greater restenosis, including 40 patients ( 8%) who developed 70% or greater restenosis of the target vessel. Patients whose histological examination of the plaque revealed marked macrophage infiltration ( n= 286) had a lower risk than those with none or minor macrophage infiltration ( n= 214) of developing 50% or greater restenosis ( risk difference, 11.5% vs 24.3%; adjusted odds ratio [ OR], 0.43; 95% confidence interval [ CI], 0.26- 0.72) and a lower risk of developing 70% or greater restenosis ( risk difference, 4.5% vs 12.6%; adjusted OR, 0.36; 95% CI, 0.17- 0.74). Patients ( n= 177) with a plaque having a large lipid core size ( > 40%) had a lower risk than those ( n= 94) with a plaque having a lipid core size of less than 10% of developing 50% or greater restenosis ( risk difference, 11.3% vs 25.5%; adjusted OR, 0.40; 95% CI, 0.19- 0.81) and a lower risk of developing 70% or greater restenosis ( risk difference, 5.6% vs 14.9%; adjusted OR, 0.42; 95% CI, 0.17- 1.04), independent of clinical characteristics. Conclusions Plaque composition is an independent predictor of restenosis after carotid endarterectomy. The dissection of a lipid- rich, inflammatory plaque is associated with reduced risk of restenosis.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 41 条
[31]  
ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
[32]   Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis [J].
Rothwell, PM ;
Eliasziw, M ;
Gutnikov, SA ;
Fox, AJ ;
Taylor, DW ;
Mayberg, MR ;
Warlow, CP ;
Barnett, HJM .
LANCET, 2003, 361 (9352) :107-116
[33]   Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries [J].
Sabeti, S ;
Mlekusch, W ;
Amighi, J ;
Minar, E ;
Schillinger, M .
JOURNAL OF ENDOVASCULAR THERAPY, 2005, 12 (01) :6-12
[34]   Measuring carotid artery stenosis -: Comparison of postmortem arteriograms with the planimetric gold standard [J].
Schulte-Altedorneburg, G ;
Droste, DW ;
Kollár, J ;
Beyna, T ;
Felszeghy, S ;
Módis, L ;
Hegedüs, C ;
Ringelstein, EB ;
Csiba, L .
JOURNAL OF NEUROLOGY, 2005, 252 (05) :575-582
[35]   PATHOLOGICAL CHARACTERISTICS OF RECURRENT CAROTID-ARTERY STENOSIS [J].
SCHWARCZ, TH ;
YATES, GN ;
GHOBRIAL, M ;
BAKER, WH .
JOURNAL OF VASCULAR SURGERY, 1987, 5 (02) :280-288
[36]   Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages [J].
Trivedi, Rikin A. ;
Mallawarachi, Chinthake ;
U-King-Im, Jean-Marie ;
Graves, Martin J. ;
Horsley, Jo ;
Goddard, Martin J. ;
Brown, Andrew ;
Wang, Liqun ;
Kirkpatrick, Peter J. ;
Brown, John ;
Gillard, Jonathan H. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) :1601-1606
[37]   Late outcome of patients with premature carotid atherosclerosis after carotid endarterectomy [J].
Valentine, RJ ;
Myers, SI ;
Hagino, RT ;
Clagett, GP .
STROKE, 1996, 27 (09) :1502-1506
[38]   Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients [J].
Verhoeven, B ;
Hellings, WE ;
Moll, FL ;
de Vries, JP ;
de Kleijn, DPV ;
de Bruin, P ;
Busser, E ;
Schoneveld, AH ;
Pasterkamp, G .
JOURNAL OF VASCULAR SURGERY, 2005, 42 (06) :1075-1081
[39]   Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design [J].
Verhoeven, BAN ;
Velema, E ;
Schoneveld, AH ;
de Vries, JPPM ;
de Bruin, P ;
Seldenrijk, CA ;
de Kleijn, DPV ;
Busser, E ;
van der Graaf, Y ;
Moll, F ;
Pasterkamp, G .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (12) :1127-1133
[40]   ENDARTERECTOMY FOR ASYMPTOMATIC CAROTID-ARTERY STENOSIS [J].
WALKER, MD ;
MARLER, JR ;
GOLDSTEIN, M ;
GRADY, PA ;
TOOLE, JF ;
BAKER, WH ;
CASTALDO, JE ;
CHAMBLESS, LE ;
MOORE, WS ;
ROBERTSON, JT ;
YOUNG, B ;
HOWARD, VJ ;
PURVIS, S ;
VERNON, DD ;
NEEDHAM, K ;
BECK, P ;
DOZIER, M ;
LEFKOWITZ, DS ;
HOWARD, G ;
CROUSE, JR ;
HERRINGTON, DM ;
FURBERG, CD ;
ESSICK, K ;
HICKS, RM ;
NELSON, JJ ;
BALL, W ;
BLAND, E ;
CONDON, S ;
ELLIOTT, T ;
GRIZZLE, JE ;
HAYES, D ;
HENLEY, S ;
JOHNSON, J ;
LOCKLEAR, J ;
MISCH, MS ;
PATON, CC ;
SCHWARTZ, S ;
WALKER, C ;
WILLIAMS, OD ;
EASTON, JD ;
GOLDSTONE, J ;
HALLENBECK, JM ;
HOFF, JT ;
KARP, HR ;
KRONMAL, RA ;
BROTT, TG ;
TOMSICK, TA ;
BRODERICK, J ;
SAUERBECK, L ;
BLUM, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (18) :1421-1428